SIBLING STUDY OF AGE-RELATED MACULAR DEGENERATION
年龄相关性黄斑变性的兄弟研究
基本信息
- 批准号:7114852
- 负责人:
- 金额:$ 61.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-30 至 2008-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): We propose to recruit pairs of siblings for a molecular genetic search for genes having a role in the development of neovascular age-related macular degeneration (AMD). Two types of sibling pairs will be recruited, extremely discordant sibpairs and extremely concordant sibpairs. Extremely discordant sibpairs will be composed of one member, the index sib, with neovascular AMD, and the second member with few or no aging signs of the macula at the age at which the index sibling developed neovascular AMD. Extremely concordant sibpairs will be composed of two siblings with neovascular AMD. Leukocyte DNA will be purified from blood samples collected from these siblings. The sibpairs will form the basis for a genome-wide linkage study to search for chromosomal regions where the extremely discordant pairs, on average, share fewer alleles than expected by chance alone, and where the extremely concordant sibpairs, on average, share more alleles than expected. Chromosomal regions having these properties are likely to harbor AMD genes. In addition, candidate genes that may have a role in susceptibility to AMD, such as ABCA4 and apoE, will be analyzed by evaluating DNA sequence variations in those genes and looking for a correlation between any alleles and neovascular AMD. To our knowledge, a molecular genetics approach to finding genes for neovascular AMD based on extremely discordant and extremely concordant sibpairs has not been previously carried out by any other group of investigators. If successful, our work should provide substantial progress toward identifying the genetic causes of neovascular AMD, one of the leading causes of legal blindness among the elderly.
描述(由申请人提供):我们建议招募成对的兄弟姐妹进行分子遗传学搜索,以寻找在新生血管性年龄相关性黄斑变性(AMD)发展中起作用的基因。将招募两种类型的同胞对,极端不一致的同胞对和极端一致的同胞对。极不一致的同胞将由一个成员(患有新生血管性AMD的指数同胞)和第二个成员组成,第二个成员在指数同胞发展新生血管性AMD的年龄时具有很少或没有黄斑老化迹象。非常一致的同胞将由患有新生血管性AMD的两个同胞组成。将从这些兄弟姐妹采集的血液样本中纯化白细胞DNA。这些同胞对将构成全基因组连锁研究的基础,以寻找染色体区域,在这些区域中,平均而言,极端不一致的对共享的等位基因比预期的少,而平均而言,极端一致的同胞对共享的等位基因比预期的多。具有这些特性的染色体区域可能含有AMD基因。此外,将通过评估这些基因的DNA序列变异并寻找任何等位基因与新生血管性AMD之间的相关性来分析可能与AMD易感性相关的候选基因,例如ABCA 4和apoE。据我们所知,分子遗传学方法来寻找基因的新生血管性AMD的基础上,非常不一致和非常一致的同胞以前没有进行任何其他组的调查。如果成功的话,我们的工作将为确定新生血管性AMD的遗传原因提供实质性的进展,新生血管性AMD是老年人法律的失明的主要原因之一。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARGARET M DEANGELIS其他文献
MARGARET M DEANGELIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARGARET M DEANGELIS', 18)}}的其他基金
Deconstructing and Modeling the Single Cell Architecture of the Age-Related Macular Degeneration Retina and RPE/Choroid
年龄相关性黄斑变性视网膜和 RPE/脉络膜的单细胞结构的解构和建模
- 批准号:
10450171 - 财政年份:2020
- 资助金额:
$ 61.73万 - 项目类别:
Deconstructing and Modeling the Single Cell Architecture of the Age-Related Macular Degeneration Retina and RPE/Choroid
年龄相关性黄斑变性视网膜和 RPE/脉络膜的单细胞结构的解构和建模
- 批准号:
10674702 - 财政年份:2020
- 资助金额:
$ 61.73万 - 项目类别:
Sibling Study of Age-Related Macular Degeneration
年龄相关性黄斑变性的兄弟研究
- 批准号:
7915557 - 财政年份:2003
- 资助金额:
$ 61.73万 - 项目类别:
SIBLING STUDY OF AGE-RELATED MACULAR DEGENERATION
年龄相关性黄斑变性的兄弟研究
- 批准号:
7277197 - 财政年份:2003
- 资助金额:
$ 61.73万 - 项目类别:
Sibling Study of Age-Related Macular Degeneration
年龄相关性黄斑变性的兄弟研究
- 批准号:
7655624 - 财政年份:2003
- 资助金额:
$ 61.73万 - 项目类别:
THE FUNCTION OF BESTROPHIN IN RETINAL DEGENERATION
Bestrophin 在视网膜变性中的作用
- 批准号:
6635598 - 财政年份:2001
- 资助金额:
$ 61.73万 - 项目类别:
THE FUNCTION OF BESTROPHIN IN RETINAL DEGENERATION
Bestrophin 在视网膜变性中的作用
- 批准号:
6518399 - 财政年份:2001
- 资助金额:
$ 61.73万 - 项目类别:
THE FUNCTION OF BESTROPHIN IN RETINAL DEGENERATION
Bestrophin 在视网膜变性中的作用
- 批准号:
6294509 - 财政年份:2000
- 资助金额:
$ 61.73万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 61.73万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 61.73万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 61.73万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 61.73万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 61.73万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 61.73万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 61.73万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 61.73万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 61.73万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 61.73万 - 项目类别:














{{item.name}}会员




